United States Biotechnology & Medical Research

Icosavax Inc (ICVX)

Track

Ticker: ICVX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Icosavax Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Feb 2024
Value US$1,067,593.41 | Price 444.32 | Shares 77,992 (+36.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-02 2024-02-01 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
77,992 +36.7%
444.32
US$1,067,593 		77,992 +36.7% 444.32 US$1,067,593
2024-01-04 2024-01-04 PrS Proposed sale
NIRANJAN KANESA-THASAN

Officer

Officer
96,407
45.78
US$273,122 		96,407 45.78 US$273,122
2024-01-04 2024-01-02 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
32,415 -12.5%
330.54
US$2,989,992 		32,415 -12.5% 330.54 US$2,989,992
2023-12-22 2023-12-21 S Sale
Simpson Adam K.

Chief Executive Officer

Executive Director
40,000 -13.3%
15.43
US$617,060 		40,000 -13.3% 15.43 US$617,060
2023-12-22 2023-12-21 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
50,000 -14.3%
15.44
US$772,220 		50,000 -14.3% 15.44 US$772,220
2023-12-21 2023-12-21 PrS Proposed sale
ADAM SIMPSON

Officer; Director

Executive Director
40,000
15.43
US$617,056 		40,000 15.43 US$617,056
2023-12-21 2023-12-21 PrS Proposed sale
ADAM K SIMPSON

Officer

Officer
95,000
15.41
US$1,463,950 		95,000 15.41 US$1,463,950
2023-12-22 2023-12-20 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
11,884 -5.0%
15.46
US$183,692 		11,884 -5.0% 15.46 US$183,692
2023-12-22 2023-12-20 S Sale
Russo Thomas Joseph

Chief Financial Officer

Officer
4,430 -10.4%
15.47
US$68,510 		4,430 -10.4% 15.47 US$68,510
2023-12-22 2023-12-20 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
10,753 -20.2%
15.46
US$166,210 		10,753 -20.2% 15.46 US$166,210
2023-12-22 2023-12-20 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
62,205 -25.2%
15.46
US$961,509 		62,205 -25.2% 15.46 US$961,509
2023-12-22 2023-12-20 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
7,934 -5.7%
15.46
US$122,637 		7,934 -5.7% 15.46 US$122,637
2023-12-20 2023-12-20 PrS Proposed sale
THOMAS RUSSO

Officer

Officer
4,430
15.47
US$68,510 		4,430 15.47 US$68,510
2023-12-20 2023-12-20 PrS Proposed sale
Niranjan Kanesa-thasan

Officer

Officer
11,884
15.46
US$183,692 		11,884 15.46 US$183,692
2023-12-20 2023-12-20 PrS Proposed sale
Thomas Joseph Russo

Officer

Officer
10,753
15.46
US$166,210 		10,753 15.46 US$166,210
2023-12-20 2023-12-20 PrS Proposed sale
Adam K. Simpson

Officer; Director

Executive Director
62,205
15.46
US$961,509 		62,205 15.46 US$961,509
2023-12-20 2023-12-20 PrS Proposed sale
Cassia Cearley

Officer

Officer
7,934
15.46
US$122,637 		7,934 15.46 US$122,637
2023-12-15 2023-12-13 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
8,759 -6.3%
16.01
US$140,190 		8,759 -6.3% 16.01 US$140,190
2023-12-13 2023-12-13 PrS Proposed sale
CASSIA CEARLEY

Officer

Officer
35,000
15.68
US$548,800 		35,000 15.68 US$548,800
2023-08-01 2023-07-31 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
3,066 -6.3%
8.86
US$27,169 		3,066 -6.3% 8.86 US$27,169
2023-08-01 2023-07-31 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
11,788 -4.6%
8.86
US$104,459 		11,788 -4.6% 8.86 US$104,459
2023-08-01 2023-07-31 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
1,888 -1.3%
8.86
US$16,731 		1,888 -1.3% 8.86 US$16,731
2023-08-01 2023-07-31 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
3,323 -1.4%
8.86
US$29,447 		3,323 -1.4% 8.86 US$29,447
2023-07-31 2023-07-31 PrS Proposed sale
Adam K. Simpson

Officer

Officer
11,788
9.17
US$108,096 		11,788 9.17 US$108,096
2023-07-31 2023-07-31 PrS Proposed sale
3.3
Douglas Andrew Holtzman

Officer

Officer
10,375
9.17
US$95,139 		10,375 9.17 US$95,139
2023-07-03 2023-07-03 PrS Proposed sale
3.3
DOUGLAS ANDREW HOLTZMAN

Officer

Officer
16,356
9.93
US$162,415 		16,356 9.93 US$162,415
2023-07-03 2023-07-03 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
2,095 -0.7%
9.59
US$20,083 		2,095 -0.7% 9.59 US$20,083
2023-07-03 2023-07-03 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
14,261 -4.7%
8.74
US$124,660 		14,261 -4.7% 8.74 US$124,660
2023-05-25 2023-05-23 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
10,000 -6.6%
10.00
US$100,000 		10,000 -6.6% 10.00 US$100,000
2023-05-23 2023-05-23 PrS Proposed sale
CASSIA CEARLEY

Officer

Officer
10,000
7.87
US$78,700 		10,000 7.87 US$78,700
2023-04-05 2023-04-03 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
300 -0.1%
6.56
US$1,968 		300 -0.1% 6.56 US$1,968
2023-04-05 2023-04-03 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
20,143 -6.5%
6.08
US$122,439 		20,143 -6.5% 6.08 US$122,439
2023-03-08 2023-03-06 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
5,000 -3.2%
7.75
US$38,737 		5,000 -3.2% 7.75 US$38,737
2023-02-15 2023-02-14 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
3,349 -1.1%
10.17
US$34,064 		3,349 -1.1% 10.17 US$34,064
2023-02-15 2023-02-13 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
1,522 -0.5%
10.69
US$16,274 		1,522 -0.5% 10.69 US$16,274
2023-02-15 2023-02-13 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
7,506 -3.0%
10.69
US$80,259 		7,506 -3.0% 10.69 US$80,259
2023-02-15 2023-02-13 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
1,902 -3.8%
10.69
US$20,337 		1,902 -3.8% 10.69 US$20,337
2023-02-15 2023-02-13 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
1,660 -1.0%
10.69
US$17,750 		1,660 -1.0% 10.69 US$17,750
2023-02-15 2023-02-13 PlS Planned sale
Bekiroglu Elizabeth

General Counsel & Corp. Sec.

Officer
5,922 -5.4%
10.69
US$63,322 		5,922 -5.4% 10.69 US$63,322
2023-02-15 2023-02-13 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
1,794 -0.7%
10.69
US$19,183 		1,794 -0.7% 10.69 US$19,183
2024-01-05 2023-01-04 S Sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
106,373 -32.2%
15.70
US$1,670,460 		106,373 -32.2% 15.70 US$1,670,460
2022-12-23 2022-12-21 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
66,764 -22.9%
8.96
US$598,406 		66,764 -22.9% 8.96 US$598,406
2022-12-16 2022-12-15 S Sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
19,648 -87.6%
11.14
US$218,963 		19,648 -87.6% 11.14 US$218,963
2022-09-09 2022-09-08 PlS Planned sale
Bekiroglu Elizabeth

General Counsel & Corp. Sec.

Officer
1,813 -1.6%
4.87
US$8,835 		1,813 -1.6% 4.87 US$8,835
2022-08-02 2022-08-02 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
495 -1.0%
6.70
US$3,318 		495 -1.0% 6.70 US$3,318
2022-08-02 2022-08-02 PlS Planned sale
Richardson Charles E

SVP, Technical Operations

Officer
371 -0.2%
6.70
US$2,487 		371 -0.2% 6.70 US$2,487
2022-08-02 2022-08-02 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
543 -0.2%
6.70
US$3,640 		543 -0.2% 6.70 US$3,640
2022-08-02 2022-08-02 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
1,904 -0.6%
6.70
US$12,764 		1,904 -0.6% 6.70 US$12,764
2022-08-02 2022-08-02 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
303 -0.2%
6.70
US$2,031 		303 -0.2% 6.70 US$2,031
2022-08-02 2022-08-02 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
453 -0.2%
6.70
US$3,037 		453 -0.2% 6.70 US$3,037
2022-08-02 2022-08-01 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
1,825 -3.6%
6.64
US$12,113 		1,825 -3.6% 6.64 US$12,113
2022-08-02 2022-08-01 PlS Planned sale
Richardson Charles E

SVP, Technical Operations

Officer
1,368 -0.8%
6.64
US$9,080 		1,368 -0.8% 6.64 US$9,080
2022-08-02 2022-08-01 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
2,001 -0.8%
6.64
US$13,281 		2,001 -0.8% 6.64 US$13,281
2022-08-02 2022-08-01 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
7,017 -2.3%
6.64
US$46,575 		7,017 -2.3% 6.64 US$46,575
2022-08-02 2022-08-01 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
1,118 -0.8%
6.64
US$7,421 		1,118 -0.8% 6.64 US$7,421
2022-08-02 2022-08-01 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
9,337 -3.1%
6.64
US$61,973 		9,337 -3.1% 6.64 US$61,973
2022-08-02 2022-07-29 PlS Planned sale
Russo Thomas Joseph

Chief Financial Officer

Officer
639 -1.2%
7.11
US$4,542 		639 -1.2% 7.11 US$4,542
2022-08-02 2022-07-29 PlS Planned sale
Richardson Charles E

SVP, Technical Operations

Officer
479 -0.3%
7.11
US$3,405 		479 -0.3% 7.11 US$3,405
2022-08-02 2022-07-29 PlS Planned sale
Kanesa-thasan Niranjan

Chief Medical Officer

Officer
701 -0.3%
7.11
US$4,982 		701 -0.3% 7.11 US$4,982
2022-08-02 2022-07-29 PlS Planned sale
Simpson Adam K.

Chief Executive Officer

Executive Director
2,456 -0.8%
7.11
US$17,456 		2,456 -0.8% 7.11 US$17,456
2022-08-02 2022-07-29 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
391 -0.3%
7.11
US$2,779 		391 -0.3% 7.11 US$2,779
2022-08-02 2022-07-29 PlS Planned sale
3.3
Holtzman Douglas

Chief Scientific Officer

Officer
585 -0.2%
7.11
US$4,158 		585 -0.2% 7.11 US$4,158
2022-04-05 2022-04-01 B Purchase
1.5
MCDADE MARK
Non-Executive Director
42,225 +526.6%
7.10
US$299,798 		42,225 +526.6% 7.10 US$299,798
2022-03-30 2022-03-29 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
8,900 +0.1%
4.75
US$42,271 		8,900 +0.1% 4.75 US$42,271
2022-03-30 2022-03-28 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
175,318 +3.0%
4.53
US$794,611 		175,318 +3.0% 4.53 US$794,611
2022-03-09 2022-03-07 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
484 -0.5%
17.81
US$8,620 		484 -0.5% 17.81 US$8,620
2022-03-09 2022-03-07 PlS Planned sale
Cearley Cassia

Chief Business Officer

Officer
9,516 -8.8%
17.13
US$163,009 		9,516 -8.8% 17.13 US$163,009
2021-08-03 2021-08-02 B Purchase
Gould Terry P
Non-Executive Director
12,368 +5.1%
15.00
US$185,520 		12,368 +5.1% 15.00 US$185,520
2021-08-03 2021-08-02 B Purchase
Gould Terry P
Non-Executive Director
26,604 +5.1%
15.00
US$399,060 		26,604 +5.1% 15.00 US$399,060
2021-08-03 2021-08-02 B Purchase
Gould Terry P
Non-Executive Director
46,381 +5.1%
15.00
US$695,715 		46,381 +5.1% 15.00 US$695,715
2021-08-03 2021-08-02 B Purchase
Gould Terry P
Non-Executive Director
47,981 +5.1%
15.00
US$719,715 		47,981 +5.1% 15.00 US$719,715
2021-08-02 2021-08-02 B Purchase
2.4
Sanofi
Large shareholder
66,667 +2.2%
15.00
US$1,000,005 		66,667 +2.2% 15.00 US$1,000,005
Explore more

More insider trading research around Icosavax Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America